Skip to main content

FDA Alerts

The FDA has approved a new dermal filler for the correction of age-related volume loss in the back of the hand for adult patients.
The US Food and Drug Administration has approved a combination therapy for patients with melanoma with BRAF V600E or V600K melanoma mutations. For administration and adverse reactions, read more.
The FDA approved a new therapy for the treatment plaque psoriasis among adult patients. For administration and adverse effects, read more.
The FDA recently approved the Supplemental New Drug Application for the use of a topical cream to treat pediatric patients with athlete's foot, jock itch, or ringworm.
The FDA has approved a generic topical solution for the treatment of chronic, moderately severe psoriasis of the scalp.
The FDA has approved a treatment for intravenous use for the adjuvant treatment of patients with melanoma with involvement of lymph nodes or metastatic disease who have undergone complete resection.
The FDA has expanded the approval of a psoriasis drug to now treat adults with psoriatic arthritis.
The FDA has approved the relabeling of an over-the-counter cream for treatment of eczema.
The FDA has expanded the approval of a dermal spray label for the treatment of atopic dermatitis.
The FDA has issued a warning to consumers and health care practitioners about serious injuries and disfigurement from using injectable silicone or products being falsely marketed as FDA-approved dermal fillers.
Back to Top